← Browse by Condition
Medical Condition
androgen deprivation therapy
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1
ClinicalMetric tracks all active clinical trials for androgen deprivation therapy sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 1 1
Top Sponsors
1 trial
1 trial
NCT07032584
Recruiting
Impact of Multimodal Telerehabilitation in Rural Patients With Metastatic Prostate Cancer
Enrollment
74 pts
Location
United States
Sponsor
University of Utah
NCT06130995 Phase 1
Recruiting
Relugolix + Enzalutamide Study in High-Risk Prostate Cancer
Enrollment
46 pts
Location
United States
Sponsor
University of Oklahoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology